Log In
BCIQ
Print this Print this
 

IL-17E

  Manage Alerts
Collapse Summary General Information
Company Aptose Biosciences Inc.
DescriptionProinflammatory cytokine interleukin-17E (IL-17E)
Molecular Target Interleukin-25 (IL-25) (IL-17E)
Mechanism of ActionImmunotherapy
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerCancer Research UK

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
Get a free BioCentury trial today